Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2055)
All Articles published online
|
Jul 14, 2006 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sporea I, Popescu A, Şirli R, Golea O, Totolici C, Dănilă M, Vernic C. Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis. World J Gastroenterol 2006; 12(26): 4191-4194 [PMID: 16830372 DOI: 10.3748/wjg.v12.i26.4191] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i26/4191.htm |
| Number | Citing Articles |
| 1 |
Thorsten Kaiser, Hans C. Damerow, Solveig Tenckhoff, Andrea Finger, Isabella Böttcher, Carsten Hafer, Anke Schwarz, Johann B. Lüth, Hans Schmidt Gürtler, Giuseppe Colucci, Michael P. Manns, Heiner Wedemeyer, Hans L. Tillmann. Kinetics of hepatitis C viral RNA and HCV‐antigen during dialysis sessions: Evidence for differential viral load reduction on dialysis. Journal of Medical Virology 2008; 80(7): 1195 doi: 10.1002/jmv.21190
|
| 2 |
Marina Berenguer. Treatment of chronic hepatitis C in hemodialysis patients. Hepatology 2008; 48(5): 1690 doi: 10.1002/hep.22545
|
| 3 |
Fabrizio Fabrizi, Paul Martin. Clinical Dilemmas in Viral Liver Disease. 2010; : 50 doi: 10.1002/9781444319590.ch11
|
| 4 |
Chen‐Hua Liu, Jia‐Horng Kao. Treatment of hepatitis C virus infection in patients with end‐stage renal disease. Journal of Gastroenterology and Hepatology 2011; 26(2): 228 doi: 10.1111/j.1440-1746.2010.06488.x
|
| 5 |
Guillermo Cabrera Álvarez, Vicente Madrid-Marina, Ricardo Jimenez-Mendez, Angel Leon Buitimea, Margarita Bahena Román, Rudyard Cortez-Gomez, Jorge Reyes Esparza, Lourdes Rodríguez-Fragoso. Combined therapy with danazol, pegilated interferon, and ribavirin improves thrombocytopenia and liver injury in rats with fibrosis. Annals of Hepatology 2007; 6(4): 233 doi: 10.1016/S1665-2681(19)31904-0
|
| 6 |
Fabrizio Fabrizi, Giovanna Lunghi, Sri Venkatesh Ganeshan, Paul Martin, Piergiorgio Messa. Reviews: Hepatitis C Virus Infection and the Dialysis Patient. Seminars in Dialysis 2007; 20(5): 416 doi: 10.1111/j.1525-139X.2007.00311.x
|
| 7 |
Fabrizio Fabrizi. Hepatitis C Virus Infection and Dialysis: 2012 Update. ISRN Nephrology 2013; 2013: 1 doi: 10.5402/2013/159760
|
| 8 |
Roberto J. Firpi, David R. Nelson. Current and Future Hepatitis C Therapies. Archives of Medical Research 2007; 38(6): 678 doi: 10.1016/j.arcmed.2006.09.002
|
| 9 |
Craig E. Gordon, Katrin Uhlig, Joseph Lau, Christopher H. Schmid, Andrew S. Levey, John B. Wong. Interferon for Hepatitis C Virus in Hemodialysis—an Individual Patient Meta-analysis of Factors Associated with Sustained Virological Response. Clinical Journal of the American Society of Nephrology 2009; 4(9): 1449 doi: 10.2215/CJN.01850309
|
| 10 |
C. Molino, F. Fabbian, M. Cozzolino, C. Longhini. The Management of Viral Hepatitis in CKD Patients: An Unresolved Problem. The International Journal of Artificial Organs 2008; 31(8): 683 doi: 10.1177/039139880803100802
|
| 11 |
A. A. Butt, Y. Ren, A. Puenpatom, J. M. Arduino, R. Kumar, A‐B. Abou‐Samra. Effectiveness, treatment completion and safety of sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir + dasabuvir in patients with chronic kidney disease: an ERCHIVES study. Alimentary Pharmacology & Therapeutics 2018; 48(1): 35 doi: 10.1111/apt.14799
|
| 12 |
Xiaoguang Liu, Pranavi Koppula, Kellen Olszewski, Boyi Gan. Thiol profiling in cancer cell lines by HPLC-mass spectrometry. STAR Protocols 2021; 2(4): 100977 doi: 10.1016/j.xpro.2021.100977
|
| 13 |
Aleksandar Sikole, Pavlina Dzekova, Nexhmi Selja, Magdalena Gaseva, Igor G. Nikolov, Mustafa Zabzun, Sheriat Muharemi, Arben Asani, Vili Amitov, Sami Mena, Violeta Grunevska, Ljubomir Ivanovski, Momir Polenakovic. Treatment of Hepatitis C in Hemodialysis Patients with Pegylated Interferon α-2a as Monotherapy. Renal Failure 2007; 29(8): 961 doi: 10.1080/08860220701641579
|
| 14 |
Takashi Akiba, Kazuhiko Hora, Michio Imawari, Chifumi Sato, Eiji Tanaka, Namiki Izumi, Takashi Harada, Ryoichi Ando, Kan Kikuchi, Tadashi Tomo, Hideki Hirakata, Tadao Akizawa. 2011 Japanese Society for Dialysis Therapy Guidelines for the Treatment of Hepatitis C Virus Infection in Dialysis Patients. Therapeutic Apheresis and Dialysis 2012; 16(4): 289 doi: 10.1111/j.1744-9987.2012.01078.x
|
| 15 |
Akira Kojima, Satoru Kakizaki, Ken‐ichi Hosonuma, Yuichi Yamazaki, Norio Horiguchi, Ken Sato, Tokuyuki Kitahara, Masatomo Mori. Interferon treatment for patients with chronic hepatitis C complicated with chronic renal failure receiving hemodialysis. Journal of Gastroenterology and Hepatology 2013; 28(4): 690 doi: 10.1111/jgh.12118
|
| 16 |
S. C. Akhan, B. Kalender, M. Ruzgar. The Response to Pegylated Interferon Alpha 2a in Haemodialysis Patients with Hepatitis C Virus Infection. Infection 2008; 36(4): 341 doi: 10.1007/s15010-008-7134-z
|
| 17 |
Guideline 3: Preventing HCV transmission in hemodialysis units. Kidney International 2008; 73: S46 doi: 10.1038/ki.2008.86
|
| 18 |
Marco Carbone, Paul Cockwell, James Neuberger. Hepatitis C and Kidney Transplantation. International Journal of Nephrology 2011; 2011: 1 doi: 10.4061/2011/593291
|
| 19 |
CHEN‐HUA LIU, CHUN‐JEN LIU, JIA‐HORNG KAO. Interferon‐based therapy for dialysis patients with chronic hepatitis C: Progress and challenges (Editorial). Nephrology 2007; 12(1): 8 doi: 10.1111/j.1440-1797.2006.00703.x
|
| 20 |
P. Deltenre, C. Moreno, A. Tran, I. Ollivier, F. Provôt, F. Stanke, M. Lazrek, H. Castel, V. Canva, A. Louvet, M. Colin, F. Glowacki, S. Dharancy, J. Henrion, M. Hazzan, C. Noel, P. Mathurin. Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy. Alimentary Pharmacology & Therapeutics 2011; 34(4): 454 doi: 10.1111/j.1365-2036.2011.04741.x
|
| 21 |
S. S. Tan, M. R. Abu Hassan, A. Abdullah, B. P. Ooi, T. Korompis, M. I. Merican. Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C. Journal of Viral Hepatitis 2009; 17(6): 410 doi: 10.1111/j.1365-2893.2009.01191.x
|
| 22 |
P.A. Grossi, A. Nanni Costa. La terapia dell'infezione da virus dell'epatite C in soggetti candidati o sottoposti a trapianto di rene. Giornale di Tecniche Nefrologiche e Dialitiche 2006; 18(3): 42 doi: 10.1177/039493620601800312
|
| 23 |
Guideline 2: Treatment of HCV infection in patients with CKD. Kidney International 2008; 73: S20 doi: 10.1038/ki.2008.85
|
| 24 |
|
| 25 |
Khalid Alsaran, Alaa Sabry, Naila Shaheen. Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience. International Urology and Nephrology 2011; 43(3): 865 doi: 10.1007/s11255-010-9756-1
|
| 26 |
Fabrizio Fabrizi, Vivek Dixit, Piergiorgio Messa, Paul Martin. Pegylated Interferon Mono‐Therapy of Chronic Hepatitis C in the Dialysis Population: Systematic Review and Meta‐Analysis. Therapeutic Apheresis and Dialysis 2015; 19(6): 611 doi: 10.1111/1744-9987.12318
|
| 27 |
Craig E. Gordon, Ethan M. Balk, Bryan N. Becker, Peter A. Crooks, Bertrand L. Jaber, Cynda A. Johnson, Maureen A. Michael, Brian J.G. Pereira, Katrin Uhlig, Adeera Levin. KDOQI US Commentary on the KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in CKD. American Journal of Kidney Diseases 2008; 52(5): 811 doi: 10.1053/j.ajkd.2008.08.005
|
| 28 |
Guideline 5: Diagnosis and management of kidney diseases associated with HCV infection. Kidney International 2008; 73: S69 doi: 10.1038/ki.2008.88
|
| 29 |
Craig E. Gordon, Katrin Uhlig, Joseph Lau, Christopher H. Schmid, Andrew S. Levey, John B. Wong. Interferon Treatment in Hemodialysis Patients With Chronic Hepatitis C Virus Infection: A Systematic Review of the Literature and Meta-analysis of Treatment Efficacy and Harms. American Journal of Kidney Diseases 2008; 51(2): 263 doi: 10.1053/j.ajkd.2007.11.003
|
| 30 |
A. Giguere, A. Anas, T. Nasser, M.H. Hassan, U. Ahmed, N. Beejay, M. Nouh, M. Khalowf, A. Saleh, A. Khan, M. Attia, G. El-Azab. Treatment of hepatitis C virus infection in patients on maintenance hemodialysis: A single United Arab Emirates center experience. European Journal of Internal Medicine 2011; 22(6): 582 doi: 10.1016/j.ejim.2011.05.008
|
| 31 |
Appendix 2: Methods for guideline development. Kidney International 2008; 73: S80 doi: 10.1038/ki.2008.121
|
| 32 |
Gabriele Zoppoli, Giovanni Di Maio, Stefania Artioli, Cristina Robaudo, Monica Basso, Francesco Torre, Giuseppe Cannella, Antonino Picciotto. Monotherapy with Pegylated Interferon Alpha‐2a in Hemodialyzed Patients with Chronic Hepatitis C. Dialysis & Transplantation 2008; 37(6): 204 doi: 10.1002/dat.20219
|
| 33 |
Guideline 4: Management of HCV-infected patients before and after kidney transplantation. Kidney International 2008; 73: S53 doi: 10.1038/ki.2008.87
|
| 34 |
Fabrizio Fabrizi, Alessio Aghemo, Piergiorgio Messa. Hepatitis C treatment in patients with kidney disease. Kidney International 2013; 84(5): 874 doi: 10.1038/ki.2013.264
|
| 35 |
E. Ridruejo, A. Cusumano, C. Diaz, M. Dávalos Michel, L. Jost, L. Jost (h.), G. Soler Pujol, O.G. Mandó, A. Vilches. Hepatitis C Virus Infection and Outcome of Renal Transplantation. Transplantation Proceedings 2007; 39(10): 3127 doi: 10.1016/j.transproceed.2007.04.023
|
| 36 |
Sukran Kose, Alp Gurkan, Fatih Akman, Mehmet Kelesoglu, Ufuk Uner. Treatment of hepatitis C in hemodialysis patients using pegylated interferon α-2a in Turkey. Journal of Gastroenterology 2009; 44(4): 353 doi: 10.1007/s00535-009-0016-z
|
| 37 |
Fabrizio Fabrizi, Paul Martin. Management of hepatitis B and C virus infection before and after renal transplantation. Current Opinion in Organ Transplantation 2006; 11(6): 583 doi: 10.1097/MOT.0b013e3280105c5c
|
| 38 |
Celal Ayaz, Mustafa Kemal Celen, Ugur Nedim Yuce, Mehmet Faruk Geyik. Efficacy and safety of pegylated-interferon α-2a in hemodialysis patients with chronic hepatitis C. World Journal of Gastroenterology 2008; 14(2): 255-259 doi: 10.3748/wjg.14.255
|
| 39 |
F. Fabrizi, G. Lunghi, V. Dixit, P. Martin. Terapia di HCV e insufficienza renale: recenti acquisizioni. Giornale di Tecniche Nefrologiche e Dialitiche 2006; 18(3): 33 doi: 10.1177/039493620601800309
|
| 40 |
Marc G. Ghany, Doris B. Strader, David L. Thomas, Leonard B. Seeff. Diagnosis, management, and treatment of hepatitis C: An update. Hepatology 2009; 49(4): 1335 doi: 10.1002/hep.22759
|
| 41 |
Paul Martin, Fabrizio Fabrizi. Hepatitis C virus and kidney disease. Journal of Hepatology 2008; 49(4): 613 doi: 10.1016/j.jhep.2008.06.003
|
| 42 |
Charles S. Whang, Ke-Qin Hu. Hepatitis C in patients with chronic kidney disease: Course and management. Current Hepatitis Reports 2007; 6(3): 96 doi: 10.1007/s11901-007-0011-x
|
| 43 |
Fabrizio Fabrizi, Piergiorgio Messa, Carlo Basile, Paul Martin. Hepatic disorders in chronic kidney disease. Nature Reviews Nephrology 2010; 6(7): 395 doi: 10.1038/nrneph.2010.37
|
| 44 |
Anita Kohli, Ali Alshati, Fawaz Georgie, Richard Manch, Robert G. Gish. Direct-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney disease. Therapeutic Advances in Gastroenterology 2016; 9(6): 887 doi: 10.1177/1756283X16665254
|
| 45 |
Fabrizio Fabrizi, Vivek Dixit, Piergiorgio Messa, Paul Martin. Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta‐analysis of clinical trials. Journal of Medical Virology 2010; 82(5): 768 doi: 10.1002/jmv.21542
|
| 46 |
T. Casanovas-Taltavull, C. Baliellas, M. Llobet, J.M. Cruzado, J. Castellote, A. Casanova, J. Niubó, C. Valls, T. Serrano. Preliminary Results of Treatment With Pegylated Interferon Alpha 2A for Chronic Hepatitis C Virus in Kidney Transplant Candidates on Hemodialysis. Transplantation Proceedings 2007; 39(7): 2125 doi: 10.1016/j.transproceed.2007.07.013
|
| 47 |
Fabrizio Fabrizi, Paul Martin. Health Care–Associated Transmission of Hepatitis B and C Viruses in Hemodialysis Units. Clinics in Liver Disease 2010; 14(1): 49 doi: 10.1016/j.cld.2009.11.011
|
| 48 |
Appendix 1: Liver biopsy in patients with CKD. Kidney International 2008; 73: S78 doi: 10.1038/ki.2008.89
|
| 49 |
D. Carriero, F. Fabrizi, A. J. Uriel, J. Park, P. Martin, D. T. Dieterich. Treatment of Dialysis Patients with Chronic Hepatitis C Using Pegylated Interferon and Low-Dose Ribavirin. The International Journal of Artificial Organs 2008; 31(4): 295 doi: 10.1177/039139880803100404
|
| 50 |
A. Mangia, P. Burra, A. Ciancio, S. Fagiuoli, M. Guido, A. Picciotto, F. Fabrizi. Hepatitis C Infection in Patients with Chronic Kidney Disease. The International Journal of Artificial Organs 2008; 31(1): 15 doi: 10.1177/039139880803100104
|
| 51 |
|
| 52 |
Marina Berenguer, Victoria Aguilera. Management of Hepatitis C in Patients with End-stage Renal Disease. Current Hepatitis Reports 2010; 9(1): 38 doi: 10.1007/s11901-009-0028-4
|
| 53 |
F. Fabrizi, V. Dixit, P. Messa, P. Martin. Interferon monotherapy of chronic hepatitis C in dialysis patients: meta‐analysis of clinical trials. Journal of Viral Hepatitis 2008; 15(2): 79 doi: 10.1111/j.1365-2893.2007.00907.x
|
| 54 |
Guideline 1: Detection and evaluation of HCV in CKD. Kidney International 2008; 73: S10 doi: 10.1038/ki.2008.84
|
| 55 |
|